Electrolyte Tablet in pharma franchise in Sikkim

Electrolyte Tablet in PCD pharma franchise in Gandhinagar

Electrolyte Tablet in top pharma company in Siliguri

Electrolyte Tablet in pcd pharma supplier in Jamshedpur

Electrolyte Tablet in phama franchise company in India
Electrolyte Tablet in phama distributor in Sangli

Home/Products /potassium-citrate-978mg-magnesium-citrate-263-point-10mg-vitamin-b6-pyridoxine-15mg-tablet

Uriviga B6 Tablet

Composition : Potassium Citrate (978mg) + Magnesium Citrate (263.10mg) + Vitamin B6 (Pyridoxine) (15mg)

Dosage Form : Tablet

Packaging Type : Alu Alu

Packaging : 10*10

Price : ₹154/-

Uriviga B6 Tablet is a carefully crafted formulation designed to support kidney health and prevent the recurrence of kidney stones. The combination of Potassium Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine) works synergistically to improve urinary pH, reduce stone formation, and maintain a healthy urinary tract environment.

Potassium Citrate helps alkalize urine by neutralizing acidity, which reduces the risk of uric acid and calcium oxalate stone formation. It also increases urinary citrate levels, a natural inhibitor of stone crystallization. Magnesium Citrate binds to oxalates in the body, lowering the chances of oxalate-based kidney stones. Vitamin B6 (Pyridoxine) contributes to reducing oxalate production and supports overall metabolic processes related to urinary health.

Uriviga B6 Tablet is particularly beneficial for individuals with a history of recurrent kidney stones, those diagnosed with hypocitraturia (low urinary citrate), or those requiring urinary pH modulation. Its tablet form ensures precise dosing and convenience, making it an excellent choice for regular use in preventive care.

Read More

About the Product

Uriviga B6 Tablet is a carefully crafted formulation designed to support kidney health and prevent the recurrence of kidney stones. The combination of Potassium Citrate, Magnesium Citrate, and Vitamin B6 (Pyridoxine) works synergistically to improve urinary pH, reduce stone formation, and maintain a healthy urinary tract environment.

Potassium Citrate helps alkalize urine by neutralizing acidity, which reduces the risk of uric acid and calcium oxalate stone formation. It also increases urinary citrate levels, a natural inhibitor of stone crystallization. Magnesium Citrate binds to oxalates in the body, lowering the chances of oxalate-based kidney stones. Vitamin B6 (Pyridoxine) contributes to reducing oxalate production and supports overall metabolic processes related to urinary health.

Uriviga B6 Tablet is particularly beneficial for individuals with a history of recurrent kidney stones, those diagnosed with hypocitraturia (low urinary citrate), or those requiring urinary pH modulation. Its tablet form ensures precise dosing and convenience, making it an excellent choice for regular use in preventive care.

Possible side effects may include mild stomach upset, nausea, or diarrhea. Rarely, hypersensitivity reactions may occur.

Uriviga B6 Tablet is indicated for the prevention of kidney stones, management of low urinary citrate levels, and maintenance of urinary pH balance.

Use under medical supervision. Avoid exceeding the prescribed dosage. If adverse reactions occur or symptoms persist, consult a healthcare provider promptly.

Store in a cool, dry place, away from direct sunlight and heat. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation